191 related articles for article (PubMed ID: 12521589)
21. Evaluation of the cytokines interleukin 8 and epithelial neutrophil activating peptide 78 as indicators of inflammation in prostatic secretions.
Hochreiter WW; Nadler RB; Koch AE; Campbell PL; Ludwig M; Weidner W; Schaeffer AJ
Urology; 2000 Dec; 56(6):1025-9. PubMed ID: 11113752
[TBL] [Abstract][Full Text] [Related]
22. Symptoms and inflammation in chronic prostatitis/chronic pelvic pain syndrome.
Krieger JN; Ross SO; Penson DF; Riley DE
Urology; 2002 Dec; 60(6):959-63. PubMed ID: 12475649
[TBL] [Abstract][Full Text] [Related]
23. Contemporary Management of Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
Magistro G; Wagenlehner FM; Grabe M; Weidner W; Stief CG; Nickel JC
Eur Urol; 2016 Feb; 69(2):286-97. PubMed ID: 26411805
[TBL] [Abstract][Full Text] [Related]
24. Fluoxetine ameliorates symptoms of refractory chronic prostatitis/chronic pelvic pain syndrome.
Xia D; Wang P; Chen J; Wang S; Jiang H
Chin Med J (Engl); 2011 Jul; 124(14):2158-61. PubMed ID: 21933619
[TBL] [Abstract][Full Text] [Related]
25. Two-year experience with the german-translated version of the NIH-CPSI in patients with CP/CPPS.
Schneider H; Brähler E; Ludwig M; Hochreiter W; Collins MF; Eremenco S; Weidner W
Urology; 2004 Jun; 63(6):1027-30. PubMed ID: 15183940
[TBL] [Abstract][Full Text] [Related]
26. Effect of antibiotic therapy on interleukin-6 in fresh semen and postmasturbation urine samples of patients with chronic prostatitis/chronic pelvic pain syndrome.
Stancik I; Plas E; Juza J; Pflüger H
Urology; 2008 Aug; 72(2):336-9. PubMed ID: 18468661
[TBL] [Abstract][Full Text] [Related]
27. Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia.
Penna G; Mondaini N; Amuchastegui S; Degli Innocenti S; Carini M; Giubilei G; Fibbi B; Colli E; Maggi M; Adorini L
Eur Urol; 2007 Feb; 51(2):524-33; discussion 533. PubMed ID: 16905241
[TBL] [Abstract][Full Text] [Related]
28. A phase II, randomized, single-blinded, placebo-controlled clinical trial on the efficacy of Curcumina and Calendula suppositories for the treatment of patients with chronic prostatitis/chronic pelvic pain syndrome type III.
Morgia G; Russo GI; Urzì D; Privitera S; Castelli T; Favilla V; Cimino S
Arch Ital Urol Androl; 2017 Jun; 89(2):110-113. PubMed ID: 28679180
[TBL] [Abstract][Full Text] [Related]
29. Chronic prostatitis/chronic pelvic pain pyndrome): seminal markers of inflammation.
Ludwig M; Vidal A; Diemer T; Pabst W; Failing K; Weidner W
World J Urol; 2003 Jun; 21(2):82-5. PubMed ID: 12690515
[TBL] [Abstract][Full Text] [Related]
30. [Basic diagnostic algorithm in chronic pelvic pain syndrome].
Kuznetskiĭ IuIa; Kurbatov DG
Urologiia; 2006; (2):62-6, 68. PubMed ID: 16708593
[TBL] [Abstract][Full Text] [Related]
31. Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial.
Nickel JC; Narayan P; McKay J; Doyle C
J Urol; 2004 Apr; 171(4):1594-7. PubMed ID: 15017228
[TBL] [Abstract][Full Text] [Related]
32. A prospective, randomized, double-blind trial to evaluate the role of a short reducing course of oral corticosteroid therapy in the treatment of chronic prostatitis/chronic pelvic pain syndrome.
Bates SM; Hill VA; Anderson JB; Chapple CR; Spence R; Ryan C; Talbot MD
BJU Int; 2007 Feb; 99(2):355-9. PubMed ID: 17313424
[TBL] [Abstract][Full Text] [Related]
33. A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis).
Nickel JC; Downey J; Pontari MA; Shoskes DA; Zeitlin SI
BJU Int; 2004 May; 93(7):991-5. PubMed ID: 15142149
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-8 levels in seminal plasma in chronic prostatitis/chronic pelvic pain syndrome and nonspecific urethritis.
Khadra A; Fletcher P; Luzzi G; Shattock R; Hay P
BJU Int; 2006 May; 97(5):1043-6. PubMed ID: 16643489
[TBL] [Abstract][Full Text] [Related]
35. Clinical efficacy of roxithromycin in men with chronic prostatitis/chronic pelvic pain syndrome in comparison with ciprofloxacin and aceclofenac: a prospective, randomized, multicenter pilot trial.
Choe HS; Lee SJ; Han CH; Shim BS; Cho YH
J Infect Chemother; 2014 Jan; 20(1):20-5. PubMed ID: 24462419
[TBL] [Abstract][Full Text] [Related]
36. Chronic prostatitis: management strategies.
Murphy AB; Macejko A; Taylor A; Nadler RB
Drugs; 2009; 69(1):71-84. PubMed ID: 19192937
[TBL] [Abstract][Full Text] [Related]
37. Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial.
Nickel JC; Downey J; Clark J; Casey RW; Pommerville PJ; Barkin J; Steinhoff G; Brock G; Patrick AB; Flax S; Goldfarb B; Palmer BW; Zadra J
Urology; 2003 Oct; 62(4):614-7. PubMed ID: 14550427
[TBL] [Abstract][Full Text] [Related]
38. Prostate-specific antigen test in diagnostic evaluation of chronic prostatitis/chronic pelvic pain syndrome.
Nadler RB; Collins MM; Propert KJ; Mikolajczyk SD; Knauss JS; Landis JR; Fowler JE; Schaeffer AJ; Alexander RB;
Urology; 2006 Feb; 67(2):337-42. PubMed ID: 16442595
[TBL] [Abstract][Full Text] [Related]
39. Effect of Essential Oil on Patients with Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Pilot Randomized Controlled Trial.
Ying J; Zhou MJ; Chen HY; Chen L; Zhang W; Ji J; Yu C; Zhang ZJ
Chin J Integr Med; 2019 Feb; 25(2):91-95. PubMed ID: 29948596
[TBL] [Abstract][Full Text] [Related]
40. Influence of environmental factors on prevalence, symptoms, and pathologic process of chronic prostatitis/chronic pelvic pain syndrome in northwest China.
Lan T; Wang Y; Chen Y; Qin W; Zhang J; Wang Z; Zhang W; Zhang X; Yuan J; Wang H
Urology; 2011 Nov; 78(5):1142-9. PubMed ID: 22054390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
